|
More
Parenteral Lyophilization
Research Library
|
|
Patheon Inc.
|
In an era characterized by the need to continuously evaluate and bolster R&D pipelines, the increasing complexity and overall cost to develop and approve drug products, the trend toward genericization, and mounting pressures to both decrease prices and maximize profitability, the pharmaceutical industry has sought competitive advantage in lower cost manufacturing jurisdictions.
The ...
|
|
|
Hyaluron - A Subsidiary of AMRI
|
The advent of bubble elimination in a prefilled syringe offers many advantages worth exploring prior to deciding how a product is to be packaged for clinical studies or commercial distribution. This technique further enhances the benefits of prefilled syringes. Prefilled syringes vs. vials have become the container of choice for parenteral drug delivery. The increase in their use is directly ...
|
|
|
Althea Technologies, Inc
|
the stability of a lyophilized igG1 monoclonal antibody was investigated using suboptimal levels of the lyoprotectant, sucrose and the incorporation of the plasticizer, sorbitol. after lyophilization, aggregation and sub-visible particle formation in the reconstituted formulations were evaluated by a number of techniques chosen to encompass a wide range of aggregate sizes. these methods included ...
|
|
|
Laureate Pharma
|
Careful planning, innovative machine design, and rigorous attention to detail will assure maximum product delivery and minimize timelines from project initiation to completion. By the time a parenteral product arrives at our facility for filling, a client has invested considerable time and significant resources in its development and manufacture. Our experiences clearly demonstrate the importance ...
|
|
|
Hyaluron - A Subsidiary of AMRI
|
Pre-filled syringes are quickly becoming a viable alternative to vials. Review the benefits they offer, including reduced overfill requirements, decreased waste and enhanced product differentiation.
Prefilled syringes are a fast- growing alternative to vials in the parenteral product market due to the many advantages they offer relative to vials. These include reduced overfill requirements, ...
|
|
|
|
